Article
New Orleans-Sufficient data are lacking to determine conclusively whether generic glaucoma products are equivalent in efficacy and safety relative to the reference legend drug
A history of the femtosecond laser in the United States and Europe
Week in Review - October 5, 2024
Factors affecting ROP development in the 8 weeks following birth
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
First patient dosed in clinical trial to treat neuropathic corneal pain
The top 10 takeaways from AAO 2024